久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Society

TCM demand grows globally

By Liu Jie and Wang Hongyi | China Daily | Updated: 2013-02-20 07:46

Foreign drugmakers explore opportunities in traditional Chinese medicine as the remedies become popular in Western markets, report Liu Jie in Beijing and Wang Hongyi in Shanghai

Traditional Chinese medicine, or TCM, holds a unique place in Chinese healthcare, which is widely accepted by the 1.3 billion Chinese - old and young, urban and rural.

Nowadays, it's also growing in popularity in Western markets, where many want to pursue a more natural lifestyle.

International drugmakers are exploring ways, including joint ventures and co-development partnerships, to combine Western approaches to drug discovery with the material repertoire of TCM.

"No matter the model, we believe this bodes well for the industry in general, as it may help accelerate TCM standardization and modernization, as well as TCM acceptance in overseas markets," said Bruce Liu, partner and co-head of the Pharma & Healthcare practice at Roland Berger Strategy Consultants.

But that expansion effort faces challenges, he added.

In November, Nestle Health Science, a fully owned subsidiary of Nestle SA, and Chi-Med, the pharmaceutical and healthcare subsidiary of Hong Kong-based Hutchison Whampoa Ltd, agreed to form a 50-50 joint venture to research, develop, manufacture and market innovative nutritional and medicinal products derived from botanical plants.

The joint venture focuses on gastrointestinal health and may in future expand into metabolic diseases and brain health, according to Nestle.

The new partnership gives Nestle access to the Chinese side's TCM library of more than 50,000 extracts from 1,200-plus herbal plants. Moreover, the Chinese side can offer TCM expertise and a botanical-based research and development platform, including discovery research, non-clinical and pharmaceutical science functions, and an understanding of the botanical guidelines and regulations for the joint venture.

"This joint venture provides us with an opportunity to develop and commercialize truly innovative and scientifically validated botanical-based nutrition," said Luis Cantarell, president and CEO of Nestle Health Science.

Other western giants have also sought out TCM opportunities. In 2009, Switzerland-based Novartis AG announced TCM-related R&D in China and plans to spend 500 million yuan ($80 million) to merge and acquire Chinese TCM enterprises in the coming years.

UK-based pharmaceutical company GlaxoSmithKline PLC has also established a new research unit in China to carry out a molecular study in TCM.

GSK said innovative TCM is an important part of the company's R&D in China, with a strategy of integrating the existing TCM knowledge of diseases with modern drug discovery technology and clinical trial methodology.

At the end of 2011, Hutchison MediPharma Ltd- a subsidiary of Chi-Med - reached an agreement with international drugmaker AstraZeneca PLC for global licensing, co-development and commercialization of Volitinib, a TCM extract that halts the progress of breast and lung cancer. Under the terms of the agreement, development costs for Volitinib in China will be shared between the two sides, with Hutchison MediPharma continuing to lead the development in China. AstraZeneca will lead and pay for the development for the rest of the world.

In addition to creating partnerships, many international pharmaceutical companies have chosen to cooperate with Chinese academic research institutes, given the local partners' rich resources of talent, basic research and academic expertise.

France's largest drug maker, Sanofi-Aventis SA, has worked with the Hong Kong University of Science and Technology to develop modern versions of traditional Chinese medicines to treat chronic diseases such as diabetes and cancer.

GSK has also established partnerships with academic bodies and TCM experts in China. "We are developing novel therapeutic TCM mixtures as prescription medicines through innovative extraction methods and combinations, and we use clinical data/evidence to differentiate from existing TCM products on the market," said Zang Jingwu, senior vice-president and head of GSK R&D China.

Novartis set up a six-year research partnership with the Shanghai Institute of Materia Medica in 2009 to identify and test the pharmacological properties of some traditional medicines.

The Shanghai institute is a unit under the Chinese Academy of Sciences and currently the largest natural-herb research base in the nation. A series of multinationals, including Johnson & Johnson Pharmaceuticals and MSD - known as Merck & Co in the United States and Canada - have established R&D cooperation agreement with the institute.

Related:

What is TCM?

Previous Page 1 2 3 Next Page

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    欧美精品在线观看一区二区| 国产精品美女久久久久aⅴ | 亚洲自拍偷拍av| 在线观看免费一区| 日韩高清在线不卡| 精品精品欲导航| 国产91富婆露脸刺激对白| 亚洲品质自拍视频| 欧美三级视频在线观看| 久久9热精品视频| 国产欧美一区二区三区在线看蜜臀 | 欧美色图12p| 麻豆专区一区二区三区四区五区| 久久一留热品黄| 成人毛片在线观看| 亚洲r级在线视频| 精品乱人伦小说| 99热在这里有精品免费| 午夜伦理一区二区| 久久久国际精品| 色88888久久久久久影院野外| 日韩国产一二三区| 欧美国产乱子伦| 精品视频999| 国产精品自在在线| 亚洲免费观看高清完整版在线观看熊| 欧美精品黑人性xxxx| 高清国产一区二区| 五月天精品一区二区三区| 国产亚洲欧美一区在线观看| 色综合色狠狠天天综合色| 日本不卡1234视频| 亚洲手机成人高清视频| 精品日韩在线一区| 91日韩精品一区| 狠狠色2019综合网| 亚洲一区二区三区四区在线观看 | 精品一区二区三区在线视频| 自拍偷在线精品自拍偷无码专区 | 亚洲视频一二区| 欧美日韩国产首页在线观看| 国产suv精品一区二区三区| 午夜一区二区三区在线观看| 国产视频一区在线观看| 欧美精品丝袜中出| 成人黄色小视频| 美美哒免费高清在线观看视频一区二区 | 国产成人精品aa毛片| 午夜电影网一区| 国产精品日日摸夜夜摸av| 欧美一区二区三区四区高清| 一本久久精品一区二区| 精品无人区卡一卡二卡三乱码免费卡 | 国产精品一卡二卡在线观看| 五月天激情综合网| 中文字幕制服丝袜成人av| 日韩久久久精品| 欧美视频在线一区二区三区 | 成人丝袜高跟foot| 老司机精品视频线观看86| 亚洲1区2区3区视频| 国产精品伦理一区二区| 欧美精品一区二区三区在线播放| 欧美日韩另类一区| 一本到高清视频免费精品| 国产高清视频一区| 麻豆精品视频在线观看| 亚洲v中文字幕| 亚洲视频一区在线观看| 欧美极品xxx| 精品国产一区二区三区忘忧草| 在线电影国产精品| 欧美色手机在线观看| 99久久国产综合精品色伊| 国产成人夜色高潮福利影视| 捆绑调教一区二区三区| 五月激情综合网| 亚洲一区二区三区免费视频| 亚洲码国产岛国毛片在线| 国产精品久久国产精麻豆99网站| 国产日韩综合av| 欧美精品一区二区久久婷婷| 日韩免费在线观看| 日韩欧美精品在线| 在线91免费看| 欧美日韩电影在线| 精品1区2区3区| 欧美性猛交xxxx黑人交| 色88888久久久久久影院野外| 99久久精品一区| 99久久精品免费看国产| eeuss国产一区二区三区| 成人av资源在线观看| 成人妖精视频yjsp地址| 成人午夜短视频| 不卡av免费在线观看| av资源网一区| aaa欧美大片| 91丨九色porny丨蝌蚪| 91一区二区三区在线观看| 91免费版在线| 色婷婷久久久综合中文字幕| 91久久国产最好的精华液| 在线一区二区三区四区| 欧美视频一区二区三区四区| 欧美日韩一二三区| 51精品秘密在线观看| 91精品午夜视频| 日韩一区二区三区免费观看| 日韩欧美国产麻豆| 久久亚洲捆绑美女| 久久九九全国免费| 国产精品女主播av| 亚洲欧美日本韩国| 亚洲国产日韩一区二区| 偷窥少妇高潮呻吟av久久免费| 日本不卡的三区四区五区| 韩国v欧美v日本v亚洲v| 国产精品99久久久久| 成人毛片老司机大片| 色8久久精品久久久久久蜜| 欧美日韩国产美女| 日韩精品资源二区在线| 久久久www成人免费毛片麻豆| 国产精品毛片久久久久久| 亚洲蜜臀av乱码久久精品蜜桃| 亚洲国产视频一区二区| 蜜臀久久99精品久久久久宅男| 国产在线精品免费| 9久草视频在线视频精品| 欧美性生活大片视频| 日韩欧美美女一区二区三区| 国产日产欧产精品推荐色| 亚洲激情自拍视频| 日韩va欧美va亚洲va久久| 国产伦精品一区二区三区免费迷 | 色综合天天综合网天天看片| 欧美三级电影在线观看| 欧美变态tickle挠乳网站| 亚洲国产精品t66y| 亚洲一二三四在线| 极品少妇xxxx偷拍精品少妇| 成人av资源站| 欧美高清hd18日本| 国产亚洲综合色| 一区二区三区色| 九九热在线视频观看这里只有精品| 粉嫩久久99精品久久久久久夜| 欧美自拍丝袜亚洲| 亚洲精品在线网站| 亚洲精品国产一区二区精华液| 美女看a上一区| 91欧美一区二区| 精品久久久久久久一区二区蜜臀| 国产精品福利一区| 日韩精品免费视频人成| 成人国产精品免费观看动漫| 51午夜精品国产| 椎名由奈av一区二区三区| 久久精品国产免费看久久精品| 北条麻妃国产九九精品视频| 91超碰这里只有精品国产| 国产精品对白交换视频| 日本成人在线不卡视频| jlzzjlzz亚洲日本少妇| 日韩欧美国产一区二区三区| 亚洲靠逼com| 国产一区二区三区黄视频 | 亚洲九九爱视频| 国产在线一区二区综合免费视频| 91久久精品午夜一区二区| 久久久www成人免费无遮挡大片| 午夜精品aaa| 99久久精品费精品国产一区二区| 日韩欧美一二三区| 一区二区三区**美女毛片| 国产精品一品二品| 欧美一区二区在线免费播放| 亚洲视频图片小说| 国产在线视频一区二区三区| 欧美久久久久久久久| 成人免费一区二区三区在线观看| 久久精品国产99国产精品| 欧美三级在线视频| 亚洲视频资源在线| 国产成人精品免费网站| 欧美va亚洲va国产综合| 亚洲成人tv网| 91视频你懂的| 久久久777精品电影网影网| 日本一道高清亚洲日美韩| 色婷婷av久久久久久久| 日本一区二区在线不卡| 久久国产精品第一页| 欧美日本国产一区| 一个色综合网站| aaa欧美色吧激情视频| 国产欧美日韩激情| 久久精品国产网站| 欧美一区二区三区免费视频|